Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF – Get Free Report)’s share price traded down 27.3% during trading on Monday . The stock traded as low as C$65.86 and last traded at C$65.86. 200 shares changed hands during mid-day trading, a decline of 85% from the average session volume of 1,300 shares. The stock had previously closed at C$90.61.
Laboratorios Farmaceuticos Rovi Stock Down 27.3 %
The stock has a fifty day moving average price of C$90.61 and a 200-day moving average price of C$89.42.
Laboratorios Farmaceuticos Rovi Company Profile
Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.
Further Reading
- Five stocks we like better than Laboratorios Farmaceuticos Rovi
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Basic Materials Stocks Investing
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Laboratorios Farmaceuticos Rovi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratorios Farmaceuticos Rovi and related companies with MarketBeat.com's FREE daily email newsletter.